Drug establishmentActive, Registered FY2026FDA warning letter on file
Sunstar Americas, Inc.
Sunstar Americas, Inc. is an FDA-registered drug establishment (FEI 1413787) located in Schaumburg, Illinois. The facility is active, registered for FY2026. Its most recent FDA inspection on record (2023-02-10) was classified VAI. FDA has issued 1 warning letter(s) to this facility.
FDA warning letter
A warning letter is FDA's formal notice of significant violations that require prompt correction. It can hold up product approvals, trigger import alerts, and put supply agreements at risk until the issues are resolved and FDA closes it out.
Recalls (2)
Recall data from openFDA enforcement reports (FDA Recall Enterprise System).
Establishment record
Inspection history
Feb 10, 2023 · Voluntary Action Indicated (VAI)
Feb 18, 2021 · Official Action Indicated (OAI)
Feb 18, 2021 · Official Action Indicated (OAI)
Feb 18, 2021 · No Action Indicated (NAI)
Jun 6, 2016 · No Action Indicated (NAI)
Dec 16, 2014 · No Action Indicated (NAI)
Dec 16, 2014 · No Action Indicated (NAI)
Dec 3, 2013 · No Action Indicated (NAI)
Dec 20, 2011 · No Action Indicated (NAI)
Oct 27, 2011 · No Action Indicated (NAI)
Oct 27, 2011 · No Action Indicated (NAI)
Questions
Is Sunstar Americas, Inc. registered with the FDA?
Yes. Sunstar Americas, Inc. is an FDA-registered drug establishment (FEI 1413787) in Schaumburg, Illinois. Its current registration status is Active, Registered FY2026.
Has Sunstar Americas, Inc. received an FDA warning letter?
Yes. FDA issued a warning letter to Sunstar Americas, Inc.; the most recent is dated Dec 21, 2021 (CGMP/QSR/Medical Devices/Adulterated).
What does Sunstar Americas, Inc. do?
Sunstar Americas, Inc.'s FDA-registered operations are: Labeling, Packaging, Relabeling, Repackaging.
Related facilities
Source: FDA public data · status as of 2026-06-06